null
100% Quality Guarantee
PhD-Level Technical Support
Key Features

Pinatuzumab Biosimilar (Anti-CD22) Antibody (HDBS0029)

SKU HDBS0029
Antibody Type Biosimilar Reference Antibody
Applications IHC
Applications FC
Applications Drug Development
Applications Pharmacokinetics
Disease Area Cancer
Protein CD22
Reactivity Human
Host Species Humanized
Isotype IgG1
€431
Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheet

Pinatuzumab (Anti-CD22) Biosimilar Antibody (HDBS0029)

The Anti-CD22 Pinatuzumab Biosimilar MAb (HDBS0029) offered by Assay Genie is a cutting-edge monoclonal antibody designed for research purposes. This biosimilar MAb specifically targets CD22, a B-cell surface antigen that is highly expressed in B-cell malignancies. This antibody is produced using state-of-the-art biotechnology methods, ensuring high specificity and sensitivity in detecting CD22 in various samples. It is validated for use in techniques such as flow cytometry, immunohistochemistry, and immunoprecipitation, making it an invaluable tool for researchers studying B-cell related diseases like leukemia and lymphoma.

The Anti-CD22 Pinatuzumab Biosimilar MAb (HDBS0029) holds great promise in advancing our understanding of B-cell biology and developing targeted therapies for B-cell derived cancers. Its high affinity for CD22 and reliable performance in experimental settings make it a valuable asset for researchers seeking to uncover new insights into the mechanisms underlying these diseases.

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose